127 related articles for article (PubMed ID: 31438723)
1. The predictive role of interleukin 6 trans-signalling in middle-aged men and women at low-intermediate risk of cardiovascular events.
Ziegler L; Frumento P; Wallén H; de Faire U; Gigante B
Eur J Prev Cardiol; 2020 Jan; 27(2):122-129. PubMed ID: 31438723
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 6 trans-signalling and risk of future cardiovascular events.
Ziegler L; Gajulapuri A; Frumento P; Bonomi A; Wallén H; de Faire U; Rose-John S; Gigante B
Cardiovasc Res; 2019 Jan; 115(1):213-221. PubMed ID: 30052808
[TBL] [Abstract][Full Text] [Related]
3. Interleukin 6 trans-signalling and the risk of future cardiovascular events in men and women.
Miri Y; Leander K; Eriksson P; Gigante B; Ziegler L
Open Heart; 2021 Oct; 8(2):. PubMed ID: 34635574
[TBL] [Abstract][Full Text] [Related]
4. Progression of conventional cardiovascular risk factors and vascular disease risk in individuals: insights from the PROG-IMT consortium.
Bahls M; Lorenz MW; Dörr M; Gao L; Kitagawa K; Tuomainen TP; Agewall S; Berenson G; Catapano AL; Norata GD; Bots ML; van Gilst W; Asselbergs FW; Brouwers FP; Uthoff H; Sander D; Poppert H; Hecht Olsen M; Empana JP; Schminke U; Baldassarre D; Veglia F; Franco OH; Kavousi M; de Groot E; Mathiesen EB; Grigore L; Polak JF; Rundek T; Stehouwer CD; Skilton MR; Hatzitolios AI; Savopoulos C; Ntaios G; Plichart M; McLachlan S; Lind L; Willeit P; Steinmetz H; Desvarieux M; Ikram MA; Johnsen SH; Schmidt C; Willeit J; Ducimetiere P; Price JF; Bergström G; Kauhanen J; Kiechl S; Sitzer M; Bickel H; Sacco RL; Hofman A; Völzke H; Thompson SG;
Eur J Prev Cardiol; 2020 Feb; 27(3):234-243. PubMed ID: 31619084
[TBL] [Abstract][Full Text] [Related]
5. Visit-to-visit variability of lipid measurements as predictors of cardiovascular events.
Waters DD; Bangalore S; Fayyad R; DeMicco DA; Laskey R; Melamed S; Barter PJ
J Clin Lipidol; 2018; 12(2):356-366. PubMed ID: 29310989
[TBL] [Abstract][Full Text] [Related]
6. Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, Triglycerides, and Apolipoprotein B and Cardiovascular Risk in Patients With Manifest Arterial Disease.
van den Berg MJ; van der Graaf Y; de Borst GJ; Kappelle LJ; Nathoe HM; Visseren FLJ;
Am J Cardiol; 2016 Sep; 118(6):804-810. PubMed ID: 27471056
[TBL] [Abstract][Full Text] [Related]
7. Risks of Incident Cardiovascular Disease Associated With Concomitant Elevations in Lipoprotein(a) and Low-Density Lipoprotein Cholesterol-The Framingham Heart Study.
Afshar M; Rong J; Zhan Y; Chen HY; Engert JC; Sniderman AD; Larson MG; Vasan RS; Thanassoulis G
J Am Heart Assoc; 2020 Sep; 9(18):e014711. PubMed ID: 32892691
[TBL] [Abstract][Full Text] [Related]
8. Circulating Proneurotensin Concentrations and Cardiovascular Disease Events in the Community: The Framingham Heart Study.
Januzzi JL; Lyass A; Liu Y; Gaggin H; Trebnick A; Maisel AS; D'Agostino RB; Wang TJ; Massaro J; Vasan RS
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1692-7. PubMed ID: 27312221
[TBL] [Abstract][Full Text] [Related]
9. Circulating Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Predicts Future Risk of Cardiovascular Events Independently of Established Risk Factors.
Leander K; Mälarstig A; Van't Hooft FM; Hyde C; Hellénius ML; Troutt JS; Konrad RJ; Öhrvik J; Hamsten A; de Faire U
Circulation; 2016 Mar; 133(13):1230-9. PubMed ID: 26896437
[TBL] [Abstract][Full Text] [Related]
10. Single and multiple cardiovascular biomarkers in subjects without a previous cardiovascular event.
Pareek M; Bhatt DL; Vaduganathan M; Biering-Sørensen T; Qamar A; Diederichsen AC; Møller JE; Hindersson P; Leósdóttir M; Magnusson M; Nilsson PM; Olsen MH
Eur J Prev Cardiol; 2017 Oct; 24(15):1648-1659. PubMed ID: 28644092
[TBL] [Abstract][Full Text] [Related]
11. Sex-specific differences in the predictive value of cholesterol homeostasis markers and 10-year cardiovascular disease event rate in Framingham Offspring Study participants.
Matthan NR; Zhu L; Pencina M; D'Agostino RB; Schaefer EJ; Lichtenstein AH
J Am Heart Assoc; 2013 Feb; 2(1):e005066. PubMed ID: 23525441
[TBL] [Abstract][Full Text] [Related]
12. Low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol and the incidence of cardiovascular disease in an urban Japanese cohort study: The Suita study.
Okamura T; Kokubo Y; Watanabe M; Higashiyama A; Miyamoto Y; Yoshimasa Y; Okayama A
Atherosclerosis; 2009 Apr; 203(2):587-92. PubMed ID: 18783774
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular Disease.
Welsh C; Celis-Morales CA; Brown R; Mackay DF; Lewsey J; Mark PB; Gray SR; Ferguson LD; Anderson JJ; Lyall DM; Cleland JG; Jhund PS; Gill JMR; Pell JP; Sattar N; Welsh P
Circulation; 2019 Aug; 140(7):542-552. PubMed ID: 31216866
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein CIII and N-terminal prohormone b-type natriuretic peptide as independent predictors for cardiovascular disease in type 2 diabetes.
Colombo M; Looker HC; Farran B; Agakov F; Brosnan MJ; Welsh P; Sattar N; Livingstone S; Durrington PN; Betteridge DJ; McKeigue PM; Colhoun HM
Atherosclerosis; 2018 Jul; 274():182-190. PubMed ID: 29793175
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals.
Nakamura T; Obata JE; Hirano M; Kitta Y; Fujioka D; Saito Y; Kawabata K; Watanabe K; Watanabe Y; Mishina H; Kugiyama K
Atherosclerosis; 2011 Sep; 218(1):163-7. PubMed ID: 21605862
[TBL] [Abstract][Full Text] [Related]
16. Atherogenic Lipoprotein Determinants of Cardiovascular Disease and Residual Risk Among Individuals With Low Low-Density Lipoprotein Cholesterol.
Lawler PR; Akinkuolie AO; Chu AY; Shah SH; Kraus WE; Craig D; Padmanabhan L; Glynn RJ; Ridker PM; Chasman DI; Mora S
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28733430
[TBL] [Abstract][Full Text] [Related]
17. Low-Density Lipoprotein Cholesterol Corrected for Lipoprotein(a) Cholesterol, Risk Thresholds, and Cardiovascular Events.
Willeit P; Yeang C; Moriarty PM; Tschiderer L; Varvel SA; McConnell JP; Tsimikas S
J Am Heart Assoc; 2020 Dec; 9(23):e016318. PubMed ID: 33222611
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol as Predictors of Cardiovascular Disease in Chinese.
Gu X; Yang X; Li Y; Cao J; Li J; Liu X; Chen J; Shen C; Yu L; Huang J; Gu D
Am J Cardiol; 2015 Oct; 116(7):1063-70. PubMed ID: 26250998
[TBL] [Abstract][Full Text] [Related]
19. The predictive study of the relation between elevated low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and mortality in peritoneal dialysis.
Lin T; Xia X; Yu J; Qiu Y; Yi C; Lin J; Mao H; Yang X; Huang F
Lipids Health Dis; 2020 Mar; 19(1):51. PubMed ID: 32199459
[TBL] [Abstract][Full Text] [Related]
20. Is Isolated Low High-Density Lipoprotein Cholesterol a Cardiovascular Disease Risk Factor? New Insights From the Framingham Offspring Study.
Bartlett J; Predazzi IM; Williams SM; Bush WS; Kim Y; Havas S; Toth PP; Fazio S; Miller M
Circ Cardiovasc Qual Outcomes; 2016 May; 9(3):206-212. PubMed ID: 27166203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
